Myotonic dystrophy disorders are caused by expanded CUG repeats in noncoding regions. Here we used Caenorhabditis elegans expressing CUG repeats to identify genes that modulate the toxicity of such repeats. We identified 15 conserved genes that function as suppressors or enhancers of CUG repeat-induced toxicity and that modulate formation of nuclear foci by CUG-repeat RNA. These genes regulate CUG repeat-induced toxicity through distinct mechanisms including RNA export and clearance, thus suggesting that CUG-repeat toxicity is mediated by multiple pathways. A subset of the genes are also involved in other degenerative disorders. The nonsense-mediated mRNA decay (NMD) pathway has a conserved role in regulating CUGrepeat-RNA transcript levels and toxicity, and NMD recognition of toxic RNAs depends on 3′-untranslated-region GC-nucleotide content. Our studies suggest a broader surveillance role for NMD in which variations in this pathway influence multiple degenerative diseases.
a r t i c l e s Expansions in nucleotide-repeat sequences cause many neuromuscular degenerative disorders 1 and can occur in noncoding as well as coding regions of genes. Expansions of CTG repeats in the 3′ untranslated region (3′ UTR) of the DMPK protein-kinase gene cause myotonic dystrophy 1 (DM1), an autosomal-dominant degenerative disease 2 . DM1 CTG expansions range to >2,000 repeats; normal CTG lengths range from 5 to 36 repeats. RNA toxicity is the cause of DM1 pathology, in which transcripts containing expanded CUG repeats accumulate in nuclei as discrete RNA foci 3 . The length of repeat expansion correlates with DM1 disease onset and severity 4, 5 . Expanded-CUG-repeat RNA transcripts disrupt alternative RNA splicing mediated by the muscleblind-like (MBNL) 6 and CUG-binding protein 1 (CUG-BP1) 7 families of RNA-binding proteins, causing toxicity. However, disruption of these splicing factors, in particular of MBNL1, does not explain the many phenotypes observed in myotonic dystrophy (DM) disorders. The identification of new factors that function as modifiers of DM1associated RNA toxicity [8] [9] [10] , and the demonstration that in a DM1 mouse model changes are detected in mRNA transcript levels and in transcript splicing that are not observed in Mbnl1-knockout mice 11, 12 , suggest the involvement of additional unknown factors and mechanisms in the pathogenesis of expanded CUG repeats.
In this study, we aimed to identify genes that mediate pathogenesis associated with expanded-CUG-repeat RNA and that may function in the pathogenic pathways of myotonic dystrophy disorders. Here we find that many of the mammalian toxic features of noncoding expanded CUG repeats can be recapitulated in C. elegans muscle. Analysis of C. elegans muscle-function defects caused by expanded CUG repeats, together with cell-biological analysis of these aberrant RNAs in wild type and in strains with a library of genes inactivated, identified gene inactivations that modify the toxicity of expanded CUG repeats and CUG-repeat foci accumulation, the hallmark of DM disorders. These modifiers of toxicity of expanded CUG repeats include the NMD pathway, which targets CUG repeat-containing transcripts for degradation. NMD regulation of CUG-repeat foci accumulation is a conserved mechanism present in both C. elegans and human cells. Recognition of these CUG repeat-containing transcripts for degradation by NMD is dependent on repeat-sequence composition.
RESULTS

Expanded CUG repeats cause C. elegans muscle defects
We generated a set of C. elegans reporter genes expressing GFP with 3′ UTRs containing various lengths of CTG repeats in body-wall muscle cells, by using the myo-3 muscle-specific promoter ( Fig. 1a) . Reporter constructs without any CUG repeats in the 384-nt 3′ UTR from the let-858 gene (denoted 0CUG) displayed strong GFP fluorescence at all developmental stages, with a modest decline during adulthood. Analogous constructs with eight CUG repeats showed similar results with mild changes in GFP fluorescence (data not shown). In contrast, the presence of 123 CUG repeats in the 3′ UTR (denoted 123CUG), a pathogenic repeat length in mammalian myocytes, resulted in a sharp decline in GFP fluorescence as animals developed into adults. Western blotting analyses revealed a sharp decrease in GFP protein levels in 3-d-old adult-stage animals of the 123CUG strain (12% compared to protein levels at the L2 larval stage). The 3-d-old adult-stage animals of the control 0CUG strain showed 50% of the GFP levels in L2 ( Fig. 1b) . We used the decline in adult-stage GFP fluorescence in123CUG transgenic animals in RNA interference (RNAi) screens to identify genes that influence the toxicity of expanded CUG repeats. a r t i c l e s We investigated the function of C. elegans muscle expressing CUG repeats by assessing locomotion phenotypes of these animals. We quantified motor defects by determining the percentage of animals that reached an attractant Escherichia coli food ring (2-cm radius) on an agar plate in 90 min ( Fig. 1c and Supplementary Fig. 1a ). The 123CUG animals exhibited severe motility deterioration at 6-d adulthood, moving about five-fold slower than wild-type or control transgenic animals, which carried 8CUG or 0CUG constructs and moved similarly to wild type. We also observed earlier locomotion defects in synchronized populations of 123CUG animals at the 2-d-old adult stage (Supplementary Fig. 1b ) and at the L4 stage (data not shown), whereas strains bearing 8CUG or 0CUG constructs showed no motility defects. Thus, expanded CUG repeats cause progressive muscle dysfunction during aging in C. elegans, as in other organisms including mammals [13] [14] [15] .
Because nuclear inclusions of expanded-CUG-repeat RNAs are characteristic of DM, we investigated whether 123CUG RNA transcripts formed nuclear foci in C. elegans muscle cells. We used single-molecule RNA fluorescence in situ hybridization (SM-FISH), which has higher sensitivity and specificity than traditional FISH 16 (Supplementary Note). The repeat-containing region of the expanded RNA transcript is known to interact inappropriately with RNA-binding proteins 17 ; therefore we chose RNA probes complementary to the GFP sequence expected to be accessible in SM-FISH. SM-FISH detected the accumulation of expanded mRNA transcripts in foci as large, often amorphous, bright fluorescent structures, with 123CUG mRNAs causing the accumulation of two to five nuclear foci per cell ( Fig. 1d) . Many individual fluorescence spots, probably corresponding to individual mRNAs, were also present in the nucleus in the 123CUG strain ( Fig. 1d) . In contrast, animals expressing 0CUG or 8CUG RNA transcripts lacked multiple bright nuclear foci and exhibited a predominantly cytoplasmic distribution of RNA 'single' transcripts ( Fig. 1d) .
For a systematic analysis of all SM-FISH data to quantify foci formation and nuclear versus cytoplasmic RNA distribution for 123CUG versus controls, we developed an algorithm that analyzed pixel intensity and cellular distribution in SM-FISH images ( Supplementary  Fig. 1c-e and Supplementary Note). We examined the SM-FISH images collected for the nuclear versus cytoplasmic distribution of CUG-repeat RNA transcripts as foci or as 'concentrated single transcripts' (high-RNA-density areas) ( Supplementary Fig. 1c-e ).
Consistently with the SM-FISH images (Fig. 1d) , the analysis of multiple 123CUG images showed a higher nuclear fluorescence intensity, which corresponded to nuclear foci and single RNA transcripts ( Fig. 1e) and was distinct from that of the control 0CUG samples. The quantitative analysis also distinguished the 8CUG from the 0CUG samples, indicating that there are fewer RNA transcripts in the nuclei of 8CUG animals compared to 0CUG animals. The mammalian splicing protein MBNL1 binds to RNA transcripts containing expanded CUG repeats 6 , and in myotonic dystrophy it is sequestered by expanded-CUG foci 18 . We examined by SM-FISH and by mosaic analysis in vivo (Supplementary Note) whether the C. elegans MBNL1 ortholog, MBL-1 (ref. 19) , bound the 123CUG foci detected in muscle cells. Expression of mbl-1 in a 123CUG background caused a marked increase in foci size relative to those in the 123CUG strain alone ( Fig. 1f,g and Supplementary  Fig. 2a-d) . Mosaic analysis showed that MBL-1 caused the retention of expanded-CUG-repeat RNA transcripts in large nuclear foci, which in turn disrupted transport to the cytoplasm and GFP translation ( Supplementary Fig. 2e and Supplementary Note). These effects were not present with GFP mRNAs with 0CUG in a strain expressing MBL-1. Thus, as it does in other organisms, MBL-1 interacts in vivo with expanded-CUG transcripts in C. elegans, and MBL-1 association with expanded-CUG-repeat transcripts decreases mRNA export to the cytoplasm and translation. Downregulation of mbl-1 by RNAi did not disrupt or enhance 123CUG-transcript foci accumulation ( Supplementary Fig. 2f ). MBL-1 downregulation, as we show below, can affect the levels of expanded-CUG transcript available for translation. These data suggest that additional regulatory factors contribute to expanded-CUG foci accumulation and toxicity. Together, our results support the hypothesis that the aggregated RNA transcripts identified by SM-FISH correspond to the key foci characteristic of DM.
Screen for modifiers of expanded CUG-mediated toxicity
To identify genes that mediate pathogenesis of expanded-CUG-repeat RNA, we used RNAi to reveal gene inactivations that can modify toxicity of expanded-CUG-repeat RNA. We performed a two-step screen, with an initial fluorescence-based RNAi screen followed by a secondary motility-based screen of hits from the primary screen ( Supplementary Fig. 3a ). For the fluorescence-based screen, we assayed for gene inactivations that disrupt the late-stage downregulation of GFP fluorescence specific to the 123CUG strain. We screened an RNAi library of 403 clones targeting genes that encode RNA-binding proteins and factors implicated in small-RNA pathways 20 . This type of sublibrary was expected to have a high representation of genes involved in toxicity of expanded CUG repeats. Of the 403 genes tested, after rescreening in triplicate, we selected 84 gene inactivations that induced an increase in late-developmental-stage GFP fluorescence specifically in the 123CUG strain without affecting the control 0CUG strain ( Fig. 2a, Supplementary Fig. 3b and Supplementary Table 1 ). We tested each of the 84 gene inactivations identified for their ability to modulate the motility defect observed in the 123CUG animals (Online Methods). The 123CUG animals on the control RNAi showed a severe loss in motility, with a median velocity of ~17 µm/s, compared to the 0CUG strain on the same control RNAi at ~100 µm/s (Fig. 2b) , a rate similar to that for wild-type animals. We identified 14 gene inactivations that significantly (P <0.01 by two-sample Kolmogorov-Smirnov test) increased or decreased the velocity of 123CUG animals without affecting the control (0CUG) animals ( Fig. 2b and Table 1 ).
The list of identified genetic modifiers of toxicity of expanded CUG repeats can be categorized into three major classes: genes involved in transcription, in signaling and in RNA processing and degradation ( Table 1) . Some of the genes identified had been previously implicated in polyglutamine (poly(Q))-repeat disorders: the hda-2, mrt-2 Genes a r t i c l e s and smg-2 genes 21-23 , corresponding to a histone deacetylase, a RAD1 911-complex DNA damage-checkpoint protein and a RNA helicase involved in the NMD pathway, respectively. We included smg-2 in the final list as an additional gene inactivation that affected both the 123CUG transgene and the 0CUG control transgene; smg-2 gene inactivation caused a mild decrease in motility of the 0CUG strain but caused a much stronger loss of motility for the 123CUG strain and was the strongest hit from the fluorescence screen for suppression of the 123CUG-specific decline in GFP fluorescence. The identification in our screen of common regulators of expanded-repeat diseases supports the view that repeat-associated disorders, in which repeats occur in either coding or noncoding regions, share several protein cofactors.
CUG-toxicity modulators affect nuclear-foci accumulation
We examined whether any of the 15 gene inactivations that modulated the toxicity of expanded CUG repeats changed RNA foci accumulation of 123CUG transcripts. One prediction is that gene inactivations that improve the motility of animals expressing 123CUG RNAs would also cause a decrease in foci size or number, and similarly gene inactivations that caused further motility impairment would lead to an increase in foci size or number ( Table 1) . Of the 15 genes identified, inactivation of ocrl-1 (inositol-1,4,5-triphosphate 5-phosphatase), str-67 (G protein-coupled chemoreceptor) and C06A1.6 led to an improvement of motility in strains expressing 123CUG in muscle ( Table 1) . Examination of GFP mRNA localization by SM-FISH in 123CUG muscles revealed a substantial reduction in the number of nuclear foci when these three genes were inactivated (Fig. 3a,b and Supplementary Figs. 4 and 5) . The suppression of 123CUG foci was particularly striking for C06A1.6 gene inactivation, in which 123CUG foci were few and small, with SM-FISH signals close to 0CUG control levels ( Fig. 3a and Supplementary Fig. 4 ). However, we still observed distribution of expanded RNA single transcripts preferentially in the nucleus versus the cytoplasm for all three gene inactivations, thus suggesting a role for ocrl-1, str-67 and C06A1.6 in foci formation rather than in cellular distribution of RNA. We found no significant changes in RNA localization, and no foci accumulation, in the control 0CUG strain when these three genes were inactivated ( Fig. 3a and Supplementary Figs. 4 and 5) . Together, these data support a model in which ocrl-1, str-67 and C06A1.6 gene activities normally enhance the toxicity of expanded CUG repeats by contributing to 123CUG foci formation, and inactivation of these genes results in decreased toxicity. For the 12 gene inactivations that further reduced motility in 123CUG animals, six gene inactivations caused an increase in foci size present in the nucleus of 123CUG body-wall muscle cells. These genes are npp-4 (nuclear-pore-complex protein), asd-1 (alternative-splicing regulator), smg-2 (NMD factor), nol-9 (polynucleotide 5′-hydroxyl-kinase), dpy-22 (transcriptional mediator protein) and R05A10.1 (Fig. 3, Table 1 and Supplementary  Figs. 4 and 5) . For some genes, such as npp-4, we observed a change in RNA localization, with transcript enrichment in the nucleus relative to the cytoplasm (Supplementary Figs. 4 and 5) . For all these genes except smg-2, we observed no significant changes in transcript distribution for the control 0CUG mRNA. smg-2 gene inactivation in the control 0CUG led to a slight increase in transcript signal, in both the nucleus and cytoplasm, without affecting nuclear-to-cytoplasm RNA distribution or leading to foci formation. Inactivation of the other six genes either caused a reduction in foci sizes or did not cause a significant change in aggregate size or number ( Table 1) . The reduction of foci number associated with an increase in toxicity suggested that, in certain conditions, the accumulation of nonaggregated CUGexpanded RNAs can be a major contributor of cellular dysfunction. Similarly to what was previously suggested 24 , these RNAs in a 'free' toxic state would have the potential to affect the activity of a wider range of RNA-binding proteins than when in an aggregated state. npg a r t i c l e s To further establish that the genes identified were involved in the regulation of expanded CUG-mediated toxicity, we overexpressed npp-4 and asd-1 as mCherry-fusion proteins in body-wall muscle cells in C. elegans. Downregulation of npp-4 and asd-1 by RNAi caused an increase in sizes of nuclear foci containing expanded-CUG RNA ( Table 1) . We analyzed C. elegans expressing these proteins fused to the fluorophore mCherry in either 123CUG or control 0CUG backgrounds by SM-FISH to assess changes in accumulation of 123CUG RNA in nuclear foci. Overexpressing either of these genes led to a decrease in foci number in a 123CUG background relative to the 123CUG parental strain (Supplementary Fig. 6a ). In contrast, overexpression of these proteins in the 0CUG strain had no effect on GFP mRNA transcript distribution. Expression of mCherry alone (Fig. 1f) , or of a different protein such as RNP-2, had no effect on 123CUG foci size or number (Supplementary Fig. 6a ). Thus some of the genes identified are dosage-sensitive components of the CUG repeat-toxicity pathway.
Nonsense-mediated decay targets 3′ UTRs with CUG repeats
smg-2 RNAi in 123CUG animals caused an increase in nuclear RNA foci sizes, an increase in muscle-cell toxicity with loss of motility and an increase in GFP fluorescence signal relative to the control. smg-2 gene inactivation on control 0CUG strains had no effect on nuclear foci, and the mild increase in toxicity detected was not comparable to that observed in the 123CUG strain. In addition, smg-2 acts as a common regulator of expanded-repeat disorders by also suppressing protein aggregation caused by expanded CAG repeats in the coding regions of the Huntingtin-encoding gene, associated with Huntington's disease 21 .
smg-2 encodes an RNA helicase and is a conserved component of the NMD pathway. The NMD pathway is an evolutionarily conserved surveillance mechanism that detects mRNAs containing premature stop codons, preventing toxic expression of truncated proteins 25 . The identification of smg-2 as a modulator of expanded-CUG toxicity suggested that the NMD pathway may recognize and target for degradation RNA transcripts with expanded CUG repeats, even in the 3′ UTRs of nontruncated open reading frames. We analyzed the effects of mutations in NMD components on GFP transcripts bearing 123CUG or control 0CUG in muscle cells, by using smg-1(r861), smg-2(qd101) and smg-6(r896) mutants. We observed that 123CUG animals in the background of in any of the mutants showed a strong increase in GFP fluorescence signal relative to the parental strain but observed no such change in fluorescence for the control 0CUG animals (Fig. 4a) . Quantitative reverse-transcription PCR (qRT-PCR) showed that mRNA levels of GFP bearing 123CUG were increased by several fold: ~5.3-fold in smg-1(r861), ~7.8-fold in smg-2(qd101) and ~10.1-fold in smg-6(r896) backgrounds, compared to wild type (Fig. 4b) . However, we observed no significant change in the levels of GFP mRNA without any CUG repeats in the 3′ UTR in the different mutant backgrounds compared to the wild type (Fig. 4b) . Thus the NMD pathway targets the mRNA transcripts containing the expanded CUG repeats for degradation.
We analyzed by SM-FISH and computational image analysis the GFP RNA transcript accumulation in 123CUG and the control 0CUG strains in the different mutant backgrounds. Disruption of the NMD pathway in 123CUG animals caused an increase in foci size and number in the nucleus ( Fig. 4c and Supplementary Fig. 6b ) and caused accumulation of foci-like structures in the cytoplasm of most cells as well (Fig. 4c,d and Supplementary Fig. 6b) . Conversely, in the mutant animals expressing the control 0CUG we observed a uniform distribution of RNA transcripts with a large number present preferentially a r t i c l e s in the cytoplasm ( Fig. 4c and Supplementary Fig. 6b ). Thus the NMD pathway recognizes RNA transcripts containing expanded CUG repeats, and disruptions in NMD cause the accumulation of expanded-CUG toxic RNA species in the nucleus, thus leading to cellular dysfunction. To examine whether the skewed sequence composition of expanded CUG repeats targets them for the NMD pathway, we explored the influence of GC composition on NMD. 3′ UTRs are typically AU rich (~65-70% AT rich), exhibiting a nucleotide composition distinct from coding (~50-55% AT rich) or intergenic regions 26, 27 . The let-858 3′ UTR to which we added the 123CUG repeat is 384 nt and 30% GC. The added CUG-repeat elements are rich in G and C nucleotides (~66%) that may contribute to recognition by the NMD pathway. We generated expression plasmids in which the 3′ UTR (CTG) n sequence was substituted by a nonrepeat sequence with either a 66% or 34% GC nucleotide content ( Supplementary Fig. 7a,b) . The DNA sequences used were cloned from non-C. elegans organisms or from entirely synthetic nucleotide sequences bearing similar GC percentages to avoid a possible recognition of endogenous signal sequences (Supplementary Note). GFP reporter genes bearing GC-rich 3′-UTR elements from non-C. elegans organisms exhibited weaker GFP fluorescence, or no fluorescence at all in the case of synthetic sequences, compared to those bearing the corresponding AT-rich elements ( Fig. 5 and Supplementary Fig. 7b) . Strains expressing GC-rich elements from a non-C. elegans genome placed in the 3′ UTR of the GFP reporter gene showed a substantial increase in fluorescence when either smg-1 or smg-2 was inactivated by RNAi, whereas we detected no change in GFP intensity for AT-rich elements ( Fig. 5  and Supplementary Fig. 7a,b) . Fusion genes engineered with synthetic, random high-GC-percentage sequences showed a stronger increase in fluorescence in the smg-2 background relative to two regulators of smg-2 phosphorylation, smg-1 or smg-6 ( Supplementary Fig. 7a,b) . These data demonstrate that the results observed for the GC-rich versus AT-rich sequences were not due to a sequence-specific endogenous 3′-UTR identity signal present in the sequence used. These results further establish that the increase in distance between the stop codon and the poly(A) signal due to the addition of the CUG-repeat sequence does not contribute to NMD recognition, because we observed no repression for AT-rich transcripts. These data support a model in which mRNAs containing CUG repeats in their 3′ UTRs are NMD substrates. Furthermore, they reveal that the NMD recognition of CUG-containing mRNA is dependent on nucleotide composition, owing either to the presence of a GC-rich sequence in a region usually AU rich or to the formation of specific secondary structures associated with the presence of these nucleotides. Although both the GC-rich 3′-UTR element and the 123CUG reporter genes are responsive to disruption of the NMD pathway, none of the 15 gene inactivations that strongly disable Figure 4 The NMD pathway modulates expanded-CUG-transcript degradation and nuclear-foci accumulation. (a) Fluorescence microscopy images of 2-d-old adult animals expressing either 123CUG repeats or 0CUG in the backgrounds wild type (WT), smg-2(qd101), smg-1(r861) and smg-6(r896). Scale bars, 200 µm. (b) qRT-PCR assay for GFP transcript levels in animals expressing either 123CUG or the control GFP in the backgrounds wild type (WT), smg-2(qd101), smg-1(r861) and smg-6(r896). Wild-type values are set at 1.0. Error bars, s.e.m. for three biological replicates, corresponding to three independent experiments in which hundreds of animals (on one full plate) were collected, and for which three technical replicates were analyzed. (c) Confocal SM-FISH images of GFP RNA transcripts (white), DAPI-stained nuclei (blue) and merge of C. elegans muscle cells. The strains imaged are 123CUG and 0CUG animals, in wild type (WT) and smg-2(qd101). Yellow arrows, expanded-CUG nuclear foci. Bar, 1 µm. (d) Computational analysis of SM-FISH images of 0CUG (green dots), 0CUG in smg-1, smg-2 or smg-6 mutant backgrounds (smg muts) (blue dots), 123CUG (red dots) and 123CUG in smg-1, smg-2 or smg-6 mutant backgrounds (black dots). Axes correspond to fraction. Thus, the detection and localization to foci of 123CUG repeats by these genes is distinct from the detection and degradation of GC-rich elements by the NMD system. To establish whether NMD recognition of expanded CUG repeats is a conserved cellular mechanism, we analyzed the phenotype of nuclear RNA foci of NMD gene inactivations in human DM1 fibroblast cells expressing 2,000 CUG repeats in the DMPK1 mRNA as well as in control fibroblasts expressing a DMPK1 mRNA with 7 to 35 such CUG repeats. We tested for changes in foci number when the human ortholog of smg-2, UPF1, was inactivated by RNAi. We used SM-FISH for RNA foci detection, with five probes complementary to the CUG-repeat region and 23 probes complementary to the last three exons of DMPK which are not composed of CUG repeats. We downregulated UPF1 with short interfering RNAs (siRNAs) in DM1 and in normal fibroblasts and analyzed cells by SM-FISH 24 h after siRNA transfection. For both control fibroblasts and fibroblasts isolated from DM1 patients, UPF1 siRNAs decreased UPF1 protein levels by 35-40% compared to scrambled siRNAs ( Supplementary  Fig. 7c,d) . There was lower cell recovery after UPF1 knockdown, thus suggesting that knockdown of NMD components may cause a loss of cell viability and may deflate the measured level of UPF1 knockdown. But even with the modest UPF1 knockdown, SM-FISH analysis revealed an increase in the number of nuclear foci in DM1 cells treated with UPF1 siRNAs compared to those in untreated DM1 cells or DM1 cells treated with mock siRNAs (Fig. 6a) . In contrast, normal fibroblast cells bearing just a few CUG repeats in the DMPK gene exhibited no nuclear foci in both untreated or UPF1-treated siRNAs (Fig. 6a) . Quantification of the number of foci present in the DM1 cells (Online Methods) showed that UPF1 downregulation caused a significant increase in the percentage of cells containing a higher number of foci (Fig. 6b) . Our data support a conserved role for NMD in the identification of transcripts bearing GC-rich sequences in their 3′ UTRs. Furthermore, our results support the function of NMD as an important element in the toxicity of expanded-CUGrepeat transcripts in myotonic dystrophy 1.
DISCUSSION
The gene inactivations that modulate phenotypes of expanded-CUG RNA repeats comprise multiple pathways, beyond those of splicing dysregulation. We demonstrate the involvement of a number of previously unknown genes as modulators of toxicity and foci formation of expanded-CUG repeats. The demonstration that different gene inactivations, all suppressors of expanded-CUG-repeat toxicity, have opposing effects on foci accumulation ( Table 1 and Supplementary  Fig. 8b) , supports the hypothesis that these genes act in distinct pathways. Genes for which a direct correlation exists between expanded-CUG-repeat toxicity and foci accumulation ( Supplementary  Fig. 8b) include genes for which modulation of expanded-RNA toxicity can occur by clearance of CUG-containing RNA transcripts, binding of expanded-CUG RNA, prevention of foci formation or promotion of mRNA transport from the nucleus. Inactivation of these genes causes an increase in the toxic expanded-CUG species present in the nucleus. One example is smg-2 inactivation. Another class of suppressor gene inactivations do not correlate with an increase in foci formation (Supplementary Fig. 8b) ; these proteins may detect cellular damage or bind to expanded CUG repeats.
The identification in our screen of additional splicing factors, such as the asd-1 and grld-1 genes, that when inactivated caused an increase in expanded-CUG toxicity was reasonable ( Table 1) . Unlike MBL1 overexpression ( Fig. 1f and Supplementary Fig. 2d) , ASD-1 overexpression led to a decrease in expanded-CUG nuclearfoci accumulation (Supplementary Fig. 6 ). ASD-1 is an alternative splicing factor belonging to the Fox-1 splicing family. In vertebrates, MBNL-encoding genes are silenced by Fox1 and Fox2 splicing factors 28 . Two mechanisms for ASD-1 suppression of toxicity of expanded CUG repeats emerge: ASD-1 regulates functional MBNL1 levels available by modulating splicing variants, and ASD-1 may bind directly or indirectly to expanded CUG repeats and affect toxicity.
Most of the gene inactivations identified make the response to expanded CUG repeats more toxic and promote the accumulation of larger RNA foci in the nuclei, thus suggesting that these genes constitute a CUG-repeat detoxification pathway that blunts the toxicity.
Commonalities have been suggested in degenerative pathways between repeat-based RNA-mediated disorders and protein-mediated disorders 1 . RNA toxicity has been implicated in poly(Q)-expansion disorders, and MBNL1 functions as a modulator of poly(Q) toxicity through its interaction with CAG-containing RNA transcripts 29 . A subset of the genes identified in our screen as modifiers of npg a r t i c l e s expanded-CUG toxicity are modulators of poly(Q) aggregation or toxicity; these include hda-2, mrt-2 and smg-2 genes 21, 23 . npp-4, although not previously linked to repeat-expansion disorders, is part of the nuclear pore complex together with npp-8, and npp-8 had been identified as a modulator of poly(Q) aggregation 30 . The identification of pathways that function as common regulators of a broad class of triplet-nucleotide pathogenic expansions supports the model of common toxic mechanisms for disorders involving coding and noncoding triplet repeats. The NMD pathway is a conserved mechanism of mRNA surveillance that regulates the expression of 5-10% of the human, fruit fly and yeast transcriptomes 31, 32 . We find that in addition to modulating its expected target transcripts, NMD modulates the abundance of transcripts containing CUG repeats in their 3′ UTRs, reducing the accumulation and nuclear-foci formation of these toxic RNA species (Supplementary Fig. 8 ) in both C. elegans and human cells ( Figs. 4  and 6 and Supplementary Fig. 6b ). Sequence composition is key in the recognition by NMD of RNA transcripts containing 3′-UTR CUGs; a similar GC-rich (~66%) sequence, when present in the 3′ UTR, is also recognized by NMD, whereas an AT-rich sequence is not.
With the identification of NMD genes as modulators of protein aggregation caused by expanded-CAG-repeats in Huntingtin, which mediates Huntington's disease 21 , our results suggest broader surveillance roles for the NMD pathway. RNA transcripts containing expanded CAG repeats, also GC rich, are likely to form secondary structures that may directly or indirectly trigger the NMD pathway 33 . Additionally, NMD has been mapped to nuclear surveillance leading to nuclear RNA degradation as well as cytoplasmic degradation. Our data showing a striking accumulation of nuclear and cytoplasmic RNA foci in NMD mutants suggest a role for NMD not only in the cytoplasm but also in nuclear clearance of expanded-RNA-repeat transcripts.
Modulation of the NMD pathway may offer a therapeutic approach for patients with myotonic dystrophy as well as for other repeat-based degenerative disorders. Pharmacological compounds that increase NMD-pathway activity may clear CUG-containing RNA toxic species, with the potential to significantly ameliorate DM-related symptoms. A comparable approach, applied to distinct disorders, is currently being tested in clinical trials of compounds that promote NMD readthrough 34 . NMD efficiency varies across tissues 35 and between individuals 36, 37 , with notable clinical implications 38 . These variations in NMD efficiency may have substantial implications for the onset or progression of trinucleotide-repeat disease.
METHODS
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